Bone Stimulators: Evidence
On this page
Direct answer
Bone stimulators apply physical energy — pulsed electromagnetic fields, capacitive coupling, implanted direct current, or low-intensity pulsed ultrasound — to persuade fractures to heal, and their story is the cleanest lesson in evidence-based orthopaedics: devices cleared by regulators decades before randomised evidence demanded it. The pivotal blow came in 2016, when a blinded randomised trial of low-intensity pulsed ultrasound in fresh tibial and distal radius fractures found no acceleration of healing over sham. The honest exam answer has two halves: name the modalities and their physics, then state that trial evidence for routine use in fresh fractures is negative or weak, with use now confined to nonunion adjuncts and patients unfit for surgery, counselled that the benefit is unproven.
What you must remember
- Four modalities: direct current (an implanted cathode at the fracture — invasive, historical); pulsed electromagnetic fields (PEMF — non-invasive induction coils); capacitive coupling (electric field plates over the limb); low-intensity pulsed ultrasound (LIPUS — the commercial EXOGEN device).
- LIPUS numbers worth quoting: 1.5 MHz carrier wave, 200-microsecond bursts repeated at 1 kHz, spatial average intensity 30 mW/cm², twenty minutes daily — the dose that was cleared in 1994 and tested in 2016.
- The pivotal trial (2016, JAMA): multicentre, blinded, placebo-controlled LIPUS in fresh tibial and distal radius fractures — no difference in time to radiographic healing or function versus sham; the study modern students must be able to cite.
- Plausible but incomplete biology: electromagnetic and mechanical stimulation are thought to mimic endogenous signals of loading — piezoelectric potentials, mechanotransduction, angiogenic upregulation; the mechanisms remain incompletely defined, which is the honest framing.
- Where advocates persist: delayed unions and established nonunions (as an adjunct, not a replacement for stability and graft), high-risk scaphoid fractures and stress fractures, and patients who refuse or cannot tolerate surgery.
- Guideline drift: major bodies have largely stopped recommending stimulators for fresh fractures; where they appear in protocols, it is as an option for recalcitrant nonunion with honest consent about mixed evidence.
- Do not confuse categories: a stimulator is physical energy; a bone graft substitute is a material; BMP is a drug — three different shelves, and mixing them loses marks.
- Indian practice reality: devices are imported, expensive and entirely out-of-pocket; for the price of a stimulator course most patients could fund grafting surgery, so use concentrates on the unfit-for-surgery patient, with the evidence discussed before the invoice.
Reading the trial evidence
The 2016 trial deserves to be understood, not just cited. Ultrasound stimulation had biological plausibility, animal data and a clearance dating to 1994 — and because devices could enter the market on substantial equivalence rather than efficacy trials, twenty years passed before a properly blinded, placebo-controlled, multicentre randomised trial asked the simple question. It enrolled fresh tibial and distal radius fractures — the everyday fractures where an effect should show — gave active or sham devices for twenty minutes daily, and blinded the assessment: the healing curves of the two arms lay on top of each other. The lesson generalises: regulatory clearance is not efficacy, plausibility is not proof, and the specialty's willingness to publish its own null result is the part worth admiring. The model viva answer runs: "the trial was negative, so I would not prescribe it for fresh fractures, though I would discuss it as an adjunct for a nonunion in a patient unfit for surgery."
The FDA-cleared trap
The MCQ tempts: "LIPUS is FDA-approved for fracture healing, therefore it accelerates union — true or false?" False, and the distinction between clearance and demonstrated efficacy is the point being examined. The companion traps are category confusion (calling BMP a stimulator, or a calcium phosphate ceramic a physical modality) and citing scaphoid advocacy as proof — the evidence there is weak and observational. Students should also hold the historical modalities straight: direct current is the implanted ancestor displaced by BMPs and better surgery; PEMF and capacitive coupling survive in limited markets; LIPUS is the one with the headline trial. Answer the physics question confidently and the efficacy question honestly, and the topic is fully scored.
Frequently asked questions
Name the physical modalities used for bone stimulation.
Implanted direct current, pulsed electromagnetic fields, capacitive coupling, and low-intensity pulsed ultrasound (LIPUS).
What did the 2016 JAMA trial of LIPUS show?
No difference in time to healing or functional outcome versus a sham device in fresh tibial and distal radius fractures — the landmark negative trial.
What are the standard LIPUS parameters?
A 1.5 MHz carrier pulsed in 200-microsecond bursts at 1 kHz, intensity 30 mW/cm², for twenty minutes daily.
Where might a bone stimulator still be reasonable?
As an adjunct for delayed union or nonunion, or for a patient unfit for or refusing further surgery — with counselling that the evidence is weak.
Why is regulatory clearance not proof of efficacy?
Devices may enter the market on equivalence pathways decided decades ago; the LIPUS story shows a cleared device failing its first properly blinded efficacy trial twenty years later.